Evidence map›Paper›PMID 41584556›Full record

ArticlePolish journal of radiology2025

Subsequent primary and secondary neoplasms in childhood cancer survivors.

Monika Bekiesińska-Figatowska, Katarzyna Bilska, Sylwia Szkudlińska-Pawlak, Teresa Klepacka, Anna Raciborska, Irena Koch, Elżbieta Michalak

Abstract read
In one paragraph

Article in Polish journal of radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Monika Bekiesińska-Figatowska *Department of Diagnostic Imaging, Institute of Mother and Child, Warsaw, Poland.
Katarzyna Bilska *Department of Oncology and Surgical Oncology for Children and Youth, Institute of Mother and Child, Warsaw, Poland.
Sylwia Szkudlińska-PawlakDepartment of Diagnostic Imaging, Institute of Mother and Child, Warsaw, Poland.
Teresa KlepackaDepartment of Pathomorphology, Institute of Mother and Child, Warsaw, Poland.
Anna RaciborskaDepartment of Oncology and Surgical Oncology for Children and Youth, Institute of Mother and Child, Warsaw, Poland.
Irena KochDepartment of Pathomorphology, Institute of Mother and Child, Warsaw, Poland.
Elżbieta MichalakDepartment of Pathomorphology, Institute of Mother and Child, Warsaw, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To count and review cases of subsequent malignant neoplasms (SMNs) in childhood cancer survivors, which are estimated to occur at a tenfold higher frequency than in the general population. Material and methods: Data of 60 patients with SMNs from a tertiary referral center for pediatric solid tumors were analyzed: gender, age at diagnosis, treatment, time between diagnoses, subsequent cancer's association with radiotherapy, observation time, status: alive/dead, genetic background. Results: Median age at time of diagnosis of the index tumor (IT) was 6.8 years (0.1-22.1), of subsequent neoplasm 14.9 years (2.1-36.6). Median time between diagnosis of first and subsequent neoplasm was 6.3 years (0.8-26.2). In 16 patients, secondary tumors developed in irradiated sites. Eleven patients (18.3%) had cancer predisposition syndromes (CPS): 3 Conclusions: Due to risk of SMNs, life-long cancer screening is required for childhood cancer survivors. In CPS, this risk is multiplied, as it results from both genetic factors and previous treatment; in these patients, multiple primary cancers must be taken into account. When assessing imaging studies of patients with a history of malignancy, clinicians should consider not only recurrence and metastases but also the possibility of a new malignancy of a different histopathological nature.

Indexed as

cancer predisposition syndromechildhood cancer survivorsubsequent malignant neoplasm

Identifiers

PMID41584556
PMCPMC12825110

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.